Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Yaseen Karim

Anesthesiology Smithtown, NY Medical Doctor

NPI 1265895783 CMS profile 11438063

994 W Jericho Tpke Ste 104, Smithtown, NY 11787

Open in the dashboard

General payments

$5,256

212 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yaseen Karim of Smithtown, NY is reported in the CMS Open Payments database as having received $5,256 across 212 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,632 67
2024 General $1,141 69
2023 General $2,482 76

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yaseen Karim
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Yaseen Karim were reported at $1,632. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Yaseen Karim Anesthesiology median Middle half National median
2019 $0 $72 $23–$151 $163
2020 $0 $36 $17–$120 $114
2021 $0 $49 $21–$135 $132
2022 $0 $52 $22–$144 $149
2023 $2,482 $53 $23–$143 $160
2024 $1,141 $55 $25–$150 $164
2025 $1,632 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Relievant Medsystems, Inc. $1,466 17 payments
  2. AbbVie, Inc. $715 35 payments
  3. Collegium Pharmaceutical, Inc. $457 51 payments
  4. Boston Scientific Corporation $401 8 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $378 42 payments
  6. Medtronic, Inc. $361 4 payments
  7. Scilex Pharmaceuticals Inc. $305 15 payments
  8. Valinor Pharma, LLC $187 10 payments
  9. Globus Medical, Inc. $167 3 payments
  10. Nevro Corp. $157 3 payments
  11. Other $662 24 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $4,299 206 payments
  2. Travel and Lodging $907 5 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50 1 payment
Products named General payments · program years 2023–2025
  1. Intracept Pain $1,466 17 payments
  2. Intracept Pain $1,466 17 payments
  3. Intracept Pain $1,466 17 payments
  4. Intracept Pain $1,466 17 payments
  5. RELISTOR $378 42 payments
  6. BOTOX $318 16 payments
  7. ZTLido $305 15 payments
  8. QULIPTA $283 14 payments
  9. BELBUCA $260 32 payments
  10. UBRELVY $258 12 payments
  11. Other $2,715 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

948

Median for Anesthesiology: 322

Drug cost

$103,670

Median for Anesthesiology: $8,738

Branded share of claims

34%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Relistor Methylnaltrexone Bromide Brand 18 $40,606
Belbuca Buprenorphine Hcl Brand 29 $23,000
Oxycontin Oxycodone Hcl Brand 20 $10,871
Movantik Naloxegol Oxalate Brand 19 $8,347
Diclofenac Sodium Generic 27 $6,577
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 118 $2,483
Lidocaine Generic 24 $2,475
Oxycodone Hcl Generic 90 $1,944
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 56 $1,808
Gabapentin Generic 132 $1,269

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$373,439

Of which drugs: $3,023

Medicare patients

707

Average age 71

Services billed

4,983

449 women, 258 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 36%
Diabetes 35%
Depression 32%
COPD 23%
Chronic kidney disease 22%
Osteoporosis 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 80 mg J1040 Office 33 36 $276
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 115 156 $45

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 15 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $154
$154 18 —
ZTLido
  • Scilex Pharmaceuticals Inc. $92
$92 — —
MOVANTIK
  • Valinor Pharma, LLC $92
$92 19 —
QULIPTA
  • AbbVie, Inc. $80
$80 — —
BOTOX
  • AbbVie, Inc. $73
$73 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 15 in the dashboard with a free account

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record